RDUS Radius Health Inc

Price (delayed)

$20.85

Market cap

$985.01M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.89

Enterprise value

$1.21B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Highlights

Radius Health's gross profit has increased by 32% YoY and by 3.7% QoQ
RDUS's net income is up by 32% year-on-year and by 20% since the previous quarter
RDUS's equity has shrunk by 191% YoY and by 75% QoQ
The debt has surged by 58% year-on-year and by 40% since the previous quarter

Key stats

What are the main financial stats of RDUS
Market
Shares outstanding
47.24M
Market cap
$985.01M
Enterprise value
$1.21B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.91
Earnings
Revenue
$246.98M
EBIT
-$61.72M
EBITDA
-$60.27M
Free cash flow
-$59.88M
Per share
EPS
-$1.89
Free cash flow per share
-$1.27
Book value per share
-$4.61
Revenue per share
$5.26
TBVPS
$4.25
Balance sheet
Total assets
$205.11M
Total liabilities
$421.12M
Debt
$342.89M
Equity
-$216.01M
Working capital
$114.29M
Liquidity
Debt to equity
-1.59
Current ratio
2.42
Quick ratio
1.75
Net debt/EBITDA
-3.79
Margins
EBITDA margin
-24.4%
Gross margin
93%
Net margin
-35.3%
Operating margin
-26%
Efficiency
Return on assets
-45.5%
Return on equity
N/A
Return on invested capital
-21.8%
Return on capital employed
-49.5%
Return on sales
-25%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RDUS stock price

How has the Radius Health stock price performed over time
Intraday
3.47%
1 week
1.21%
1 month
6%
1 year
65.34%
YTD
16.74%
QTD
-0.05%

Financial performance

How have Radius Health's revenue and profit performed over time
Revenue
$246.98M
Gross profit
$229.72M
Operating income
-$64.24M
Net income
-$87.3M
Gross margin
93%
Net margin
-35.3%
RDUS's operating margin has soared by 53% YoY and by 25% from the previous quarter
The net margin has increased by 47% year-on-year and by 23% since the previous quarter
The operating income is up by 39% YoY and by 22% QoQ
Radius Health's gross profit has increased by 32% YoY and by 3.7% QoQ

Growth

What is Radius Health's growth rate over time

Valuation

What is Radius Health stock price valuation
P/E
N/A
P/B
N/A
P/S
3.97
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.91
The EPS has grown by 32% YoY and by 20% from the previous quarter
RDUS's equity has shrunk by 191% YoY and by 75% QoQ
The P/S is 97% lower than the 5-year quarterly average of 144.7 but 20% higher than the last 4 quarters average of 3.2
The company's revenue rose by 29% YoY and by 3.5% QoQ

Efficiency

How efficient is Radius Health business performance
The ROS has soared by 53% YoY and by 26% from the previous quarter
Radius Health's return on invested capital has increased by 37% YoY and by 27% QoQ
The ROA has grown by 21% YoY and by 20% from the previous quarter

Dividends

What is RDUS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RDUS.

Financial health

How did Radius Health financials performed over time
The company's total assets is 51% lower than its total liabilities
RDUS's total liabilities has soared by 53% YoY and by 34% from the previous quarter
The quick ratio is down by 37% YoY and by 5% from the previous quarter
RDUS's equity has shrunk by 191% YoY and by 75% QoQ
The debt has surged by 58% year-on-year and by 40% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.